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Metastatic malignant ovarian melanoma – a case report
Metastatski maligni melanom ovarijuma
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Abstract
Background. Malignant melanomas of the female repro-
ductive system are rare. These are biologically highly aggres-
sive tumors with poor prognosis. Preoperative establish-
ment of the diagnosis is practically impossible. Therapeutic
approach and treatment of patients with metastatic ovarian
melanoma are highly dependent on precise histological
analysis. Case report. A woman aged 48 was admitted to
the clinic for occasional pains in the lower abdomen and
suspected myomatous changes of the uterus. The patient
underwent surgery for melanoma on her right arm five years
ago. Classic hysterectomy with bilateral adnexectomy with
infracolic omentectomy and selective iliac lymphadenec-
tomy were performed. Macroscopic examination revealed
an oval tumefaction on the left ovary sized 12.5 x 10 x 3.5
cm of solid structure. Tumor tissue was yellowish-brown
colored, of solid structure and mostly localized subcortically
with central edema. Microscopic examination showed posi-
tive reaction for HMB-45, anti-Melan-A and S-100 protein,
but negative immunoreactivity for estrogen and progester-
one receptors. Malignant disease caused death after a 4-year
follow-up period following gynecological operation. Con-
clusion. The previous diagnosis of skin melanoma is also
indicative of metastatic ovarian tumor, while immunohisto-
chemical analyses confirmed the histopathological diagnosis.
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Apstrakt
Uvod. Maligni melanomi ženskog reproduktivnog sistema
su retki. To su biološki veoma agresivni tumori sa lošom
prognozom. Postavljanje dijagnoze pre operacije je gotovo
nemoguýe. Terapijski pristup i leÿenje bolesnika sa metas-
tatskim ovarijalnim melanomom veoma zavisi od precizne
histološke dijagnoze. Prikaz bolesnika. Žena, stara 48
godina, primljena je na kliniku zbog povremenih bolova u
donjem delu abdomena i zbog sumnje na miomatozno iz-
menjenu matericu. Pet godina ranije imala je operaciju
melanoma desne ruke. UraĀena je klasiÿna histerektomija
sa obostranom adneksektomijom i parcijalnom resekcijom
omentuma sa selektivnom ilijaÿnom limfadenektomijom.
Makroskopski, opisan je ovalni tumefakt levog ovarijuma
12,5 x 10 x 3,5 cm solidne strukture. Tumor je bio žuýka-
stobraon boje, uglavnom lokalizovan supkortikalno sa
centralnim edemom. Mikroskopsko ispitivanje je pokazalo
pozitivnu reakciju na HMB-45, anti-melan-A and S-100
protein, ali negativnu imunoreaktivnost na estrogenske i
progesteronske receptore. Progresija maligne bolesti do-
vela je do smrti posle 4-godišnjeg praýenja bolesnice na-
kon ginekološke operacije. Zakljuÿak. Prethodna dijagno-
za melanoma kože upuýuje na metastatski ovarijalni tu-
mor, dok imunohistohemijske analize potvrĀuju histopa-
tološku dijagnozu.
Kljuÿne reÿi:
jajnik, neoplazme; melanom; neoplazme, metastaze;
dijagnoza; hirurgija, ginekološka, procedure; leÿenje,
ishod.
Introduction
It has been known that different gynecological malignan-
cies extend toward the ovary by direct invasion as well as that
gastrointestinal adenocarcinoma and breast cancer are the most
frequent non-gynecological malignancies metastasizing to the
ovaries. Ovarian localization of secondary deposits of extrao-
varian malignancies is relatively frequent and it accounts for
approximately 10% of all ovarian tumors 
1.
Malignant melanomas of the female reproductive system
are rare and they account for 3%–7% of all melanoma locali-
zations. Less than 50 cases have been described in the litera-
ture so far. These are biologically highly aggressive tumors
with poor prognosis and most of the patients die within initial
two years after verification of the tumor. Primary malignant
melanoma of the ovary is exceptionally rare in gynecological
oncology. It may develop as a result of malignant transforma-
tion of  melanocytes in mature cystic ovarian teratoma 
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Preoperative establishment of the diagnosis is practi-
cally impossible since occasionally the tumor is not clinically
manifested as adnexal or ovarian mass, although history of
previous treatment of melanoma of other localization may
rise suspicion 
4–6.
Therapeutic approach and treatment of patients with
metastatic ovarian melanoma are highly dependent on pre-
cise histological analysis. Establishment of the accurate di-
agnosis is a prerequisite and imperative for the therapy 
7–9.
We presented a case with secondary malignant mela-
noma of the ovary following previously treated melanoma on
the arm.
Case report
A woman aged 48 was admitted to the clinic for occa-
sional pains in the lower abdomen and suspected myomatous
changes of the uterus.
The patient had no specific gynecological history, had
two vaginal deliveries and two artificial abortions. Five years
ago the patient underwent surgery for melanoma on her right
arm while two years ago she had gallbladder surgery.
Clinical gynecological examination revealed solid, un-
even uterus with palpable tumefaction on the left side, adja-
cent to the uterus of approximately 10 cm in diameter. Ultra-
sound examination of the small pelvis evidenced uterus size
of 11 x 7 x 5 cm, with subserous myoma arising from the
fundus sized 10 x 8 cm. Pathologic adnexal findings were
defined neither on the right nor on the left side.
Preoperative results of blood analyses were normal, in-
cluding blood count and liver and kidney functions, while
erythrocyte sedimentation was slightly increased. Tumor
markers CEA, CA 15-3 i CA 19-9 in the serum were within
the normal range, while CA 125 was discreetly increased.
Lung and heart x-rays as well, echosonography of the abdo-
men were normal.
In the course of laparotomy, a small quantity of ascites
was aspirated. The left ovary with tumefaction sized 10 x 8
cm was in the immediate contact with the uterus, twice tor-
qued around its axis. Surface of the tumefaction was roughly
nodular and uneven. The right ovary and fallopian tube as
well as the uterus appeared normal. The abdominal organs
accessible to examination were free of any visible pathologi-
cal changes.
Classic hysterectomy with bilateral adnexectomy with
infracolic omentectomy and selective iliac lymphadenectomy
were performed. Surgical material undergone histopathologi-
cal analysis.
Macroscopic examination revealed an oval tumefaction
on the left ovary sized 12.5 x 10 x 3.5 cm of solid structure
and whitish, roughly nodular surface (Figure 1). On the sec-
tion, tumor tissue was yellowish-brown colored, of solid
structure and mostly localized subcortically with central
edema. The uterus, left ovary, fallopian tube, omentum and
lymph nodes were normal.
Microscopic examination revealed the presence of tu-
mor in the left ovary, composed of  solid islets, nests or
band-like formations. Tumor cells were polygonal, occasion-
ally fusiform with oval, pleomorphic, hyperchromic nuclei.
Mitoses numbers were moderate (Figure 2). The tumor did
not penetrate the ovarian capsule or spread to the contralat-
eral ovary, uterus, omentum or two analyzed lymph nodes.
Fig. 1 – Macroscopic finding of ovary with malignant
melanoma
Fig. 2 – Malignant melanoma (HE, x 400)
The tumor cells showed marked cytoplasmic immu-
noreactivity to HMB-45 (Figure 3) and anti-Melan-A (Figure
4), as well as to S-100 protein (Figure 5), however with
somewhat lower intensity of staining. Immunohistochemical
reaction to estrogen and progesterone receptors was negative.
Accordingly, the diagnosis of malignant metastatic
ovarian melanoma was established.
The postoperative course was uneventful. Progression
of the malignant disease caused death of the patient after a 4-
year follow-up period following gynecological operation,
nine years after the surgery for primary malignant melanoma
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Fig. 3 – Diffuse expression of HMB-45 antibodies
Fig. 4 – Focal expression of anti-Melan-A antibodies
Fig. 5 – Diffuse expression of S-100 protein
Discussion
Melanomas of the female genital tract are known to be
rare and they are most commonly biologically highly aggres-
sive and lethal tumors 
10. The interval between primary
melanoma and ovarian metastasis is about 78 months 
2, but
in our case report it was 60 months.
This ovarian neoplasm is, as a rule, unilateral, and it is
mostly detected in postmenopausal women averagely aged
53 years. Based on the reference data, the patients present
due to the abdominal bloating and occasional pains in the
small pelvis. Gynecological palpation reveals tumor masses,
however the findings are occasionally inconclusive and also
indicative of benign lesions of the genital organs, as it was
the case with our patient. If the disease is accompanied by
dysuria and loss of body weight or signs of acute abdomen,
more detailed investigations and treatment are indicated in
order to establish the exact diagnosis 
11, 12.
Occasional abdominal pain was the major symptom in
the reported patient. Ultrasound examination of the pelvis
failed to evidence possible presence of a malignant process
while tumor change was interpreted as subserous myoma of
the uterus. It has been known that the presence of melanin in
the course of magnetic resonance imaging may show
changes in signal acquisition. Our patient did not undergo
magnetic resonance imaging since malignant tumor in the
small pelvis was not suspected.
More detailed clinical examination of the skin and visi-
ble mucosal membranes failed to evidence melanoma of any
other localization or other secondary deposits and based on
the history, pigmented skin tumor was confirmed. It is as-
sumed that spontaneous regression of the primary lesion
sometimes occurred 
10.
The tumor was unilateral, which is a frequent charac-
teristic of secondary melanoma, its structure was solid, yel-
lowish colored and it infiltrated extensively the ovarian tis-
sue, without penetration of the capsule. No residues of the
teratomatous component were found in the tumor, which was
important for determination of the primary nature of mela-
noma 
2, 7.
In the reported case, the tumor was subjected to detailed
histopathological examination and no teratomatous elements
were detected, while previously diagnosed skin melanoma
was suggestive of the metastatic nature of the tumor.
Establishment of the accurate histopathological diagno-
sis and evaluation of differential diagnostic possibilities of
other ovarian neoplasm require verification based on immu-
nohistochemical demonstration of S-100 proteins i HMB-45
and negative staining for keratin and other antigens 
7, 12. In
case of our patient, histopathological diagnosis was con-
firmed immunohistochemically by positive tumor cell stain-
ing for HMB-45, anti-Melan-A and S-100 protein.
Reductive surgery is currently considered to be the
most important approach to treatment of malignant ovarian
melanoma, although different additional protocols of che-
motherapy and radiotherapy are also available, as well as at-
tempted treatments based on application of immunotherapy.
The treatment of the patient included total hysterectomy andStrana 232 VOJNOSANITETSKI PREGLED Volumen 70, Broj 2
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bilateral adnexectomy with selective iliac lymphadenectomy
and infracolic omentectomy 
3, 5.
Conclusion
The presented patient shows that seemingly insignifi-
cant and occasional painful sensations in the small pelvis
may be the result of a highly malignant process, which may
occasionally lead to misdiagnosis of primary benign tumor
owing to its localization and structure. The absence of tera-
tomatous component in malignant ovarian melanoma evi-
denced by histopathological analysis is indicative of secon-
dary deposits. The previous diagnosis of skin melanoma was
also indicative of metastatic ovarian tumor, while immuno-
histochemical analyses confirmed the histopathological di-
agnosis.
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